The DOI matches its Crossref record; 209 of the 212 references it cites were found in a registry or an index.
A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder
Open accessAbstract
A growing body of data suggests that hyperactivation of the immune system has been implicated in the pathophysiology of major depressive disorder (MDD). Several pro-inflammatory cytokines, such as tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) have been found to be significantly increased in patients with MDD. This review focuses on these two cytokines based on multiple lines of evidence from genetic, animal behaviour, and clinical studies showing that altered levels of serum TNF-alpha and IL-1 are associated with increased risk of depression, cognitive impairments, and reduced responsiveness to treatment. In addition, recent findings have shown that centrally expressed TNF-alpha and IL-1 play a dual role in the regulation of synaptic plasticity. In this paper, we review and critically appraise the mechanisms by which cytokines regulate synaptic and neural plasticity, and their implications for the pathophysiology and treatment of MDD. Finally, we discuss the therapeutic potential of anti-inflammatory-based approaches for treating patients with severe mood disorders. This is a promising field for increasing our understanding of the mechanistic interaction between the immune system, synaptic plasticity, and antidepressants, and for the ultimate development of novel and improved therapeutics for severe mood disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the proinflammatory cytokines IL-1, IL-6, TNF-α, and IFN-γ have been implicated in neuronal development, neuroplasticity, synaptogenesis, and tissue repair[15].”
From Neuroinflammation and cytokine abnormality in major depression: cause or consequence in that illness? (2016) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A synaptic model of memory: long-term potentiation in the hippocampus
Bliss, T. V. P., & Collingridge, G. L. (1993) · Nature · doi:10.1038/361031a0 · Cited by 11,566
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
(2015) · American Journal Of Pathology · doi:10.2353/ajpath · Cited by 4,961
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Signalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793
Squire, L. R., Stark, C. E. L., & Clark, R. E. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144130 · Cited by 2,680
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
Synaptic scaling mediated by glial TNF-α
Stellwagen, D., & Malenka, R. C. (2006) · Nature · doi:10.1038/nature04671 · Cited by 1,715
The stressed hippocampus, synaptic plasticity and lost memories
Kim, J. J., & Diamond, D. M. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn849 · Cited by 1,543
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
Control of Synaptic Strength by Glial TNFα
Beattie, E. C., Stellwagen, D., Morishita, W., Bresnahan, J. C., Ha, B. K., Von Zastrow, M., Beattie, M. S., & Malenka, R. C. (2002) · Science · doi:10.1126/science.1067859 · Cited by 1,344
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Maier, S. F., & Watkins, L. R. (1998) · Psychological Review · doi:10.1037/0033-295x.105.1.83 · Cited by 1,130
Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(05)67763-x · Cited by 1,069 · cited 2×
“…Johnson, USA) has been found to attenuate the depressive symptoms that Downloaded from https://academic.oup.com/ijnp/article-abstract/12/4/561/657745 by guest on 29 July 2018 accompany immune system activation in psoriasis (Dantzer, 1999; Krishnan et al. 2007; Tyring et al. 2006; Yirmiya, 2000).”
BackgroundDifferential Regulation of AMPA Receptor and GABA Receptor Trafficking by Tumor Necrosis Factor-α
Stellwagen, D., Beattie, E. C., Seo, J. Y., & Malenka, R. C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4486-04.2005 · Cited by 985
Course of illness, hippocampal function, and hippocampal volume in major depression
MacQueen, G. M., Campbell, S., McEwen, B. S., Macdonald, K., Amano, S., Joffe, R. T., Nahmias, C., & Young, L. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337481100 · Cited by 980
Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.
Tkachev, D., Mimmack, M., Ryan, M. M., Wayland, M., Freeman, T., Jones, P., Starkey, M., Webster, M., Yolken, R., & Bahn, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14289-4 · Cited by 940
Sickness behavior as a new target for drug development
Kent, S., Bluthé, R.-M., Kelley, K. W., & Dantzer, R. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90012-u · Cited by 867
Journal of Affective Disorders
Flint, A. J., & Rifat, S. L. (1996) · Journal of Affective Disorders · doi:10.1016/0165-0327(96)00074-2 · Cited by 864
Cytokine‐Induced Sickness Behavior: Mechanisms and Implications
Dantzer, R. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05827.x · Cited by 825
Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells
Rajkowska, G. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00950-1 · Cited by 822
Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001805 · Cited by 794
Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment
Warner‐Schmidt, J. L., & Duman, R. S. (2006) · Hippocampus · doi:10.1002/hipo.20156 · Cited by 787
Chronic stress alters dendritic morphology in rat medial prefrontal cortex
Cook, S. C., & Wellman, C. L. (2004) · Journal of Neurobiology · doi:10.1002/neu.20025 · Cited by 785
Lieberman, A. P., Pitha, P. M., Shin, H. S., & Shin, M. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6348 · Cited by 783
Goshen, I., Kreisel, T., Ben-Menachem-Zidon, O., Licht, T., Weidenfeld, J., Ben-Hur, T., & Yirmiya, R. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002055 · Cited by 762
Acute cortisone administration impairs retrieval of long-term declarative memory in humans
de Quervain, D. J.-F., Roozendaal, B., Nitsch, R. M., McGaugh, J. L., & Hock, C. (2000) · Nature Neuroscience · doi:10.1038/73873 · Cited by 745
Cytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735
Kendler, K. S., Thornton, L. M., & Gardner, C. O. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.8.1243 · Cited by 721
Uranova, N. A., Vostrikov, V. M., Orlovskaya, D. D., & Rachmanova, V. I. (2004) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00181-6 · Cited by 659
Choudary, P. V., Molnar, M., Evans, S. J., Tomita, H., Li, J., Vawter, M. P., Myers, R., Bunney, W. E., Akil, H., Watson, S. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507901102 · Cited by 653
Depression: a case of neuronal life and death?
Duman, R. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.033 · Cited by 630
Gliogenesis and Glial Pathology in Depression
Rajkowska, G., & Miguel-Hidalgo, J. J. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707780619326 · Cited by 625
Maes, M., Meltzer, H. Y., Bosmans, E., Bergmans, R., Vandoolaeghe, E., Ranjan, R., & Desnyder, R. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00028-l · Cited by 622
Glial Loss in the Prefrontal Cortex Is Sufficient to Induce Depressive-like Behaviors
Banasr, M., & Duman, R. S. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.06.008 · Cited by 622
Chung, I. Y., & Benveniste, E. N. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.8.2999 · Cited by 609
Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
Boka, G., Anglade, P., Wallach, D., Javoy-Agid, F., Agid, Y., & Hirsch, É. C. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90684-x · Cited by 600
Rajkowska, G., Halaris, A. E., & Selemon, L. D. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01080-0 · Cited by 572
Decreased memory performance in healthy humans induced by stress-level cortisol treatment
Newcomer, J. W. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.6.527 · Cited by 546
A dual role for interleukin-1 in hippocampal-dependent memory processes
Goshen, I., Kreisel, T., Ounallah-Saad, H., Renbaum, P., Zalzstein, Y., Ben‐Hur, T., Levy‐Lahad, E., & Yirmiya, R. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.09.004 · Cited by 535
Evidence for the involvement of TNF and NF-?B in hippocampal synaptic plasticity
Albensi, B. C., & Mattson, M. P. (2000) · Synapse · doi:10.1002/(sici)1098-2396(200002)35:2 · Cited by 527
Manji, H. K., Quiroz, J. A., Sporn, J., Payne, J. L., Denicoff, K. D., Gray, N. A., Zarate, C. A., & Charney, D. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00117-3 · Cited by 507
Self-citation“Inflammatory” Cytokines: Neuromodulators in Normal Brain?
Vitkovic, L., Bockaert, J., & Jacque, C. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740457.x · Cited by 506
Stress and Plasticity in the Limbic System
Sapolsky, R. M. (2003) · Neurochemical Research · doi:10.1023/a:1026021307833 · Cited by 503
A neuromodulatory role of interleukin-1β in the hippocampus
Schneider, H., Pitossi, F., Balschun, D., Wagner, A., del Rey, A., & Besedovsky, H. O. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7778 · Cited by 498
Sheline, Y. I. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00994-x · Cited by 496
Depression, stress and immunological activation: The role of cytokines in depressive disorders
Connor, T. J., & Leonard, B. E. (1998) · Life Sciences · doi:10.1016/s0024-3205(97)00990-9 · Cited by 480
Czéh, B., Simon, M., Schmelting, B., Hiemke, C., & Fuchs, E. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300982 · Cited by 434
Cunningham, A. J., Murray, C. A., O'Neill, L. A. J., Lynch, M. A., & O'Connor, J. J. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(95)12252-4 · Cited by 433
p53: 25 years after its discovery
Hofseth, L. J., Hussain, S. P., & Harris, C. C. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.02.009 · Cited by 428
Clinical depression and inflammatory risk markers for coronary heart disease
Miller, G. E., Stetler, C. A., Carney, R. M., Freedland, K. E., & Banks, W. A. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02863-1 · Cited by 424
Actions of TNF‐α on glutamatergic synaptic transmission in the central nervous system
Pickering, M., Cumiskey, D., & O'Connor, J. J. (2005) · Experimental Physiology · doi:10.1113/expphysiol.2005.030734 · Cited by 421
Neuropsychiatric Symptoms Associated With Hepatitis C and Interferon Alpha: A Review
Dieperink, E. W., Willenbring, M., & Ho, S. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.867 · Cited by 417
On the nature and pattern of neurocognitive function in major depressive disorder.
Zakzanis, K. K., Leach, L., & Kaplan, E. (1998) · PubMed · Cited by 406
Avital, A., Goshen, I., Kamsler, A., Segal, M., Iverfeldt, K., Richter‐Levin, G., & Yirmiya, R. (2003) · Hippocampus · doi:10.1002/hipo.10135 · Cited by 396
Interleukin 1β inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus
Bellinger, F. P., Madamba, S. G., & Siggins, G. R. (1993) · Brain Research · doi:10.1016/0006-8993(93)90959-q · Cited by 393
Tuglu, C., Kara, S. H., Caliyurt, O., Vardar, E., & Abay, E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1566-z · Cited by 391
Heyser, C. J., Masliah, E., Samimi, A., Campbell, I. L., & Gold, L. H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1500 · Cited by 386
Cytokine Actions in the Central Nervous System
Benveniste, E. N. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(98)00015-x · Cited by 383
Effects of antidepressants on the production of cytokines
Kenis, G., & Maes, M. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003164 · Cited by 370
Murray, C. A., & Lynch, M. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-08-02974.1998 · Cited by 359
Journal of Neural Transmission
(2013) · Journal of Neural Transmission · doi:10.1007/702.1435-1463 · Cited by 354
Pramipexole for bipolar II depression: a placebo-controlled proof of concept study
Zarate, C. A., Payne, J. L., Singh, J. B., Quiroz, J. A., Luckenbaugh, D. A., Denicoff, K. D., Charney, D. S., & Manji, H. K. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.03.013 · Cited by 343
Self-citationJin, C., & Reed, J. C. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm832 · Cited by 340
Padmos, R. C., Hillegers, M. H. J., Knijff, E. M., Vonk, R., Bouvy, A., Staal, F. J. T., de Ridder, D., Kupka, R. W., Nolen, W. A., & Drexhage, H. A. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.395 · Cited by 336
Cunningham, E. T., Wada, E., Carter, D., Tracey, D. E., Battey, J., & Souza, E. B. D. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-03-01101.1992 · Cited by 331
Iwamoto, K., Kakiuchi, C., Bundo, M., Ikeda, K., & Kato, T. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001437 · Cited by 331
Manji, H. K., Duman, R. S., Duman, F. A. R. S., & PhD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4260 · Cited by 330
Self-citationThe psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans
Wichers, M., & Maes, M. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003103 · Cited by 329
An Open-Label Trial of Riluzole in Patients With Treatment-Resistant Major Depression
Zarate, C. A., Payne, J. L., Quiroz, J. A., Sporn, J., Denicoff, K. K., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.171 · Cited by 327
Self-citationTumor necrosis factor alters synaptic transmission in rat hippocampal slices.
Tancredi, V., D'Arcangelo, G., Grassi, F., Tarroni, P., Palmieri, G., Santoni, A., & Eusebi, F. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90071-e · Cited by 326
Cytokine imbalance in the pathophysiology of major depressive disorder
Kim, Y., Na, K.-S., Shin, K.-H., Jung, H., Choi, S., & Kim, J.-B. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.03.004 · Cited by 319
Interleukin‐6: a cytokine to forget
Balschun, D., Wetzel, W., del Rey, A., Pitossi, F. J., Schneider, H., Zuschratter, W., & Besedovsky, H. O. (2004) · The FASEB Journal · doi:10.1096/fj.04-1625fje · Cited by 317
Pro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline Therapy
Sutcigil, L., Oktenli, C., Musabak, U., Bozkurt, A., Cansever, A., Uzun, O., Sanisoglu, S. Y., Yesilova, Z., Ozmenler, N., Ozsahin, A., et al. (2007) · Clinical and Developmental Immunology · doi:10.1155/2007/76396 · Cited by 315
Acute Stress-induced Changes in Hippocampal/Prefrontal Circuits in Rats: Effects of Antidepressants
Rocher, C. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhg122 · Cited by 307
Psychoneuroimmunology and the cytokine action in the CNS: Implications for psychiatric disorders
Müller, N., & Ackenheil, M. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(97)00179-6 · Cited by 305
Sun, X., Zhao, Y., & Wolf, M. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4603-04.2005 · Cited by 299
The monocyte-T-lymphocyte hypothesis of major depression
Maes, M., Smith, R., & Simon, S. (1995) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)00066-j · Cited by 299
Nery, F. G., Monkul, E. S., Hatch, J. P., Fonseca, M., Zunta‐Soares, G. B., Frey, B. N., Bowden, C. L., & Soares, J. C. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.912 · Cited by 298
Behavioral Effects of Cytokines
Larson, S. J., & Dunn, A. J. (2001) · Brain Behavior and Immunity · doi:10.1006/brbi.2001.0643 · Cited by 295
Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder
Eller, T., Vasar, V., Shlik, J., & Maron, E. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.09.015 · Cited by 290
Inflammation, Glutamate, and Glia in Depression:A Literature Review
McNally, L., Bhagwagar, Z., & Hannestad, J. (2008) · CNS Spectrums · doi:10.1017/s1092852900016734 · Cited by 289
Psychomotor stimulants and neuronal plasticity
Wolf, M. E., Sun, X., Mangiavacchi, S., & Chao, S. Z. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.006 · Cited by 288
Cytokine profiles in bipolar affective disorder: focus on acutely ill patients.
O'Brien, S. M., Scully, P., Scott, L. V., & Dinan, T. G. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.11.015 · Cited by 285
Illness, Cytokines, and Depression
YIRMIYA, R., POLLAK, Y., MORAG, M., REICHENBERG, A., BARAK, O., AVITSUR, R., SHAVIT, Y., OVADIA, H., WEIDENFELD, J., MORAG, A., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05412.x · Cited by 284
Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse?
Carlezon, W. A., & Nestler, E. J. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02289-0 · Cited by 281
Lacroix, S., & Rivest, S. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70020452.x · Cited by 280
Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus
Bonaccorso, S., Marino, V., Biondi, M., Grimaldi, F., Ippoliti, F., & Maes, M. H. J. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00264-1 · Cited by 280
Fontana, A., Weber, E., & Dayer, J. M. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.4.1696 · Cited by 277
Rivest, S., Lacroix, S., Vallières, L., Nadeau, S., Zhang, J., & Laflamme, N. (2000) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.2000.22304.x · Cited by 277
Cellular Plasticity Cascades: Targets for the Development of Novel Therapeutics for Bipolar Disorder
Zarate, C. A., Singh, J. B., & Manji, H. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.021 · Cited by 275
Self-citationEastwood, S. L., & Harrison, P. J. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00530-5 · Cited by 265
Cavanagh, J., Beck, M. V., Muir, W. J., & Blackwood, D. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.180.4.320 · Cited by 264
Barrientos, R. M., Higgins, E. A., Sprunger, D. B., Watkins, L. R., Rudy, J. W., & Maier, S. F. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00043-8 · Cited by 263
Cellular Plasticity Cascades in the Pathophysiology and Treatment of Bipolar Disorder
Schloesser, R. J., Huang, J. Y., Klein, P. S., & Manji, H. K. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301575 · Cited by 262
Self-citationTNFα Signaling in Depression and Anxiety: Behavioral Consequences of Individual Receptor Targeting
Simen, B. B., Duman, C. H., Simen, A. A., & Duman, R. S. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.013 · Cited by 255
Clinical depression and regulation of the inflammatory response during acute stress
Miller, G. E., Rohleder, N., Stetler, C., & Kirschbaum, C. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000174172.82428.ce · Cited by 253
Pathways linking depression, adiposity, and inflammatory markers in healthy young adults
Miller, G. E., Freedland, K. E., Carney, R. M., Stetler, C., & Banks, W. A. (2003) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(03)00057-6 · Cited by 252
Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation
Pugh, C. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00098-4 · Cited by 251
Wagoner, N. J. V., Oh, J., Repovic, P., & Benveniste, E. N. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-13-05236.1999 · Cited by 250
Tancredi, V., D’Antuono, M., Café, C., Giovedı̀, S., Buè, M. C., D’Arcangelo, G., Onofri, F., & Benfenati, F. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750634.x · Cited by 249
Peripheral and central proinflammatory cytokine response to a severe acute stressor
O'Connor, K. A., Johnson, J. D., Hansen, M. K., Wieseler Frank, J. L., Maksimova, E., Watkins, L. R., & Maier, S. F. (2003) · Brain Research · doi:10.1016/j.brainres.2003.08.006 · Cited by 247
Bonaccorso, S., Puzella, A., Marino, V., Pasquini, M., Biondi, M., Artini, M., Almerighi, C., Levrero, M., Egyed, B., Bosmans, E., et al. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00315-8 · Cited by 235
Hestad, K. A., Tønseth, S., Støen, C. D., Ueland, T., & Aukrust, P. (2003) · The Journal of ECT · doi:10.1097/00124509-200312000-00002 · Cited by 235
Anti-inflammatory properties of desipramine and fluoxetine
Roumestan, C., Michel, A., Bichon, F., Portet, K., Detoc, M., Henriquet, C., Jaffuel, D., & Mathieu, M. N. (2007) · Respiratory Research · doi:10.1186/1465-9921-8-35 · Cited by 234
Interleukin-1β, but not interleukin-6, impairs spatial navigation learning
Oitzl, M. S., van Oers, H. J. J., Schöbitz, B., & de Kloet, E. R. (1993) · Brain Research · doi:10.1016/0006-8993(93)90468-3 · Cited by 234
Xu, L., Hölscher, C., Anwyl, R., & Rowan, M. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3204 · Cited by 234
Madrigal, J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00292-5 · Cited by 232 · cited 2×
“…pre-clinical and clinical evidence indicate that acute and chronic stress elevates levels of proinflammatory cytokines, such as IL-1 and TNF-a and activates their signalling pathways in the periphery and CNS (Deinzer et al. 2004; Goebel et al. 2000; Madrigal et al. 2002; O’Connor et al. 2003).”
BackgroundThe long-term potential of LTP
Malenka, R. C. (2003) · Nature reviews. Neuroscience · doi:10.1038/nrn1258 · Cited by 229
Brain Interleukin-1 Is Involved in Spatial Memory and Passive Avoidance Conditioning
Yirmiya, R. (2002) · Neurobiology of Learning and Memory · doi:10.1006/nlme.2002.4072 · Cited by 228
Breder, C. D., Tsujimoto, M., Terano, Y., Scott, D. W., & Saper, C. B. (1993) · The Journal of Comparative Neurology · doi:10.1002/cne.903370403 · Cited by 226
Cytokines, Stress, and Depression
Dantzer, R., Wollman, E. E., Vitković, L., & Yirmiya, R. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-0-585-37970-8_17 · Cited by 220
Gibertini, M., Newton, C. A., Friedman, H., & Klein, T. (1995) · Brain Behavior and Immunity · doi:10.1006/brbi.1995.1012 · Cited by 219
Butler, M. P., O'Connor, J. J., & Moynagh, P. N. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.11.040 · Cited by 218
Dieperink, E. W., Ho, S. B., THURAS, P. D., & Willenbring, M. L. (2003) · Psychosomatics · doi:10.1176/appi.psy.44.2.104 · Cited by 217
Cytokines and serotonin transporter in patients with major depression
Tsao, C.-W., Lin, Y.-S., Chen, C.-C., Bai, C., & Wu, S.-R. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.01.029 · Cited by 215
Du, J., Suzuki, K., Wei, Y., Wang, Y., Blumenthal, R., Chen, Z., Falke, C., Zarate, C. A., & Manji, H. K. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301178 · Cited by 213
Self-citationSchizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission
Müller, N., & Schwarz, M. (2006) · Neurotoxicity Research · doi:10.1007/bf03033242 · Cited by 212
A Placebo-Controlled Pilot Study of the Ampakine CX516 Added to Clozapine in Schizophrenia
GOFF, D. C., Leahy, L., Berman, I., Posever, T. A., Herz, L. R., Leon, A. C., Johnson, S. A., & LYNCH, G. S. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200110000-00005 · Cited by 209
Involvement of Tumor Necrosis Factor Alpha in Hippocampal Development and Function
Golan, H. M. (2003) · Cerebral Cortex · doi:10.1093/cercor/bhg108 · Cited by 204
Low levels of circulating inflammatory cytokines—Do they affect human brain functions?
Pollmächer, T., Haack, M., Schuld, A., Reichenberg, A., & Yirmiya, R. (2002) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00004-1 · Cited by 202
Capuron, L., Ravaud, A., Gualde, N., Bosmans, E., Dantzer, R., Maes, M., & Neveu, P. J. (2001) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00030-0 · Cited by 201
Antidepressants inhibit interferon-γ-induced microglial production of IL-6 and nitric oxide
Hashioka, S., Klegeris, A., Monji, A., Kato, T., Sawada, M., McGeer, P. L., & Kanba, S. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.03.022 · Cited by 198
Clark, R. E., Broadbent, N., Zola, S. M., & Squire, L. R. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04663.2002 · Cited by 196
Gadient, R. A., & Otten, U. (1994) · Brain Research · doi:10.1016/0006-8993(94)91211-4 · Cited by 195
Goebel, M. U., Mills, P. J., Irwin, M. R., & Ziegler, M. G. (2000) · Psychosomatic Medicine · doi:10.1097/00006842-200007000-00019 · Cited by 189
Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia
Vawter, M. P., Thatcher, L. N., Usen, N., Hyde, T. M., Kleinman, J. E., & Freed, W. J. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001158 · Cited by 188
Delayed cytokine expression in rat brain following experimental contusion
Holmin, S., Schalling, M., Höjeberg, B., Nordqvist, A. S., Skeftruna, A.-K., & Mathiesen, T. I. (1997) · Journal of neurosurgery · doi:10.3171/jns.1997.86.3.0493 · Cited by 186
Tchélingérian, J., Quinonero, J., Booss, J., & Jacque, C. (1993) · Neuron · doi:10.1016/0896-6273(93)90312-f · Cited by 185
Enhanced Long-Term Synaptic Depression in an Animal Model of Depression
Holderbach, R., Clark, K., Moreau, J., Bischofberger, J., & Normann, C. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.007 · Cited by 182
Nuclear factor-κB/Rel proteins
Grilli, M., & Memo, M. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00214-7 · Cited by 180
Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats
Bluthé, R.-M., Castanon, N., Pousset, F., Bristow, A., Ball, C., Lestage, J., Michaud, B., KELLEY, K. W., & Dantzer, R. (1999) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(98)00077-8 · Cited by 179
Maier, S. F., & Watkins, L. R. (1995) · Brain Research · doi:10.1016/0006-8993(95)00930-o · Cited by 178
Shakesby, A. C., Anwyl, R., & Rowan, M. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03638.2002 · Cited by 173
Regulation of Neurogenesis and Gliogenesis by Stress and Antidepressant Treatment
Banasr, M., & Duman, R. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707783220929 · Cited by 169
Stewart, C. A., & Reid, I. (2000) · Psychopharmacology · doi:10.1007/s002130050045 · Cited by 157
Du, J., Gray, N. A., Falke, C. A., Chen, W., Yuan, P., Szabo, S. T., Einat, H., & Manji, H. K. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1258-04.2004 · Cited by 157
Self-citationGABA and glutamate systems as therapeutic targets in depression and mood disorders
Kendell, S. F., Krystal, J. H., & Sanacora, G. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.1.153 · Cited by 154
Immune system dysregulation in adolescent major depressive disorder
Gabbay, V., Klein, R. G., Alonso, C. M., Babb, J. S., Nishawala, M., De Jesus, G., Hirsch, G. S., Hottinger-Blanc, P. M. Z., & Gonzalez, C. J. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.07.022 · Cited by 153
Capuron, L., Ravaud, A., & Dantzer, R. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200105000-00007 · Cited by 148
Mizuta, I., Ohta, M., Ohta, K., Nishimura, M., Mizuta, E., & Kuno, S. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02098-5 · Cited by 145
Different immune patterns in melancholic and non-melancholic major depression
Rothermundt, M., Arolt, V., Fenker, J., Gutbrodt, H., Peters, M., & Kirchner, H. (2001) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060170058 · Cited by 143
Maes, M. H. J., Bockstaele, D. R. V., Gastel, A. V., Song, C., Schotte, C., Neels, H. M., Meester, I. D., Scharpé, S., & Janca, A. (1999) · Neuropsychobiology · doi:10.1159/000026552 · Cited by 143
Expression of type I and type II interleukin-1 receptors in mouse brain
Parnet, P., Amindari, S., Wu, C., Brunke-Reese, D., Goujon, E., Weyhenmeyer, J. A., Dantzer, R., & Kelley, K. W. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90185-6 · Cited by 142
Friedman, W. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7595 · Cited by 140
Curran, B. P., & O'Connor, J. J. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00405-5 · Cited by 138
Cell pathology in mood disorders
Rajkowska, G. (2002) · Seminars in Clinical Neuropsychiatry · doi:10.1053/scnp.2002.35228 · Cited by 135 · cited 1×
“…abnormalities in hippocampal and frontal cortex areas in patients with MDD or BPD, especially those who have experienced multiple episodes (Bielau et al. 2005; MacQueen et al. 2003; Ongur et al. 1998; Rajkowska, 2000, 2002; Rajkowska et al. 2001; Rajkowska&Miguel-Hidalgo, 2007; Sheline, 2000).”
BackgroundIncreased soluble interleukin‐2 receptor concentrations in suicide attempters
Nässberger, L., & Träskman‐Bendz, L. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03412.x · Cited by 135
Volume deficits of subcortical nuclei in mood disorders
Bielau, H., Trübner, K., Krell, D., Agelink, M. W., Bernstein, H., Stauch, R., Mawrin, C., Dános, P., Gerhard, L., Bogerts, B., et al. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0581-y · Cited by 133
Schaaf, M. J. M., Hoetelmans, R. W. M., de Kloet, E. R., & Vreugdenhil, E. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970515)48:4 · Cited by 131
Asefa, B., Klarmann, K. D., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., & Keller, J. R. (2003) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2003.10.002 · Cited by 131
Coogan, A. N., O'Neill, L. A. J., & O'Connor, J. J. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00100-1 · Cited by 129
Blood levels of cytokines in elderly patients with major depressive disorder
Brambilla, F., & Maggioni, M. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb10005.x · Cited by 128
Taler, M., Gil‐Ad, I., Lomnitski, L., Korov, I., Baharav, E., Bar, M., Zolokov, A., & Weizman, A. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.03.010 · Cited by 121
Krishnan, R. R., Cella, D. F., Leonardi, C., Papp, K. A., Gottlieb, A. B., Dunn, M. E., Chiou, C. F., Patel, V. D., & Jahreis, A. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08205.x · Cited by 121
Medana, I. M., Hunt, N. H., & Chaudhri, G. (1997) · Europe PMC (PubMed Central) · Cited by 120
D’Arcangelo, G., Tancredi, V., Onofri, F., D’Antuono, M., Giovedı̀, S., & Benfenati, F. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00011.x · Cited by 117
Jun, T., Pae, C., Hoon-Han, Chae, J., Bahk, W., Kim, K., & Serretti, A. (2003) · Psychiatric Genetics · doi:10.1097/00041444-200309000-00008 · Cited by 113
Kubera, M., Kenis, G., Bosmans, E., Zieba, A., Dudek, D., Nowak, G., & Maes, M. H. J. (2000) · PubMed · Cited by 110
The Role of Hippocampal GluR1 and GluR2 Receptors in Manic-Like Behavior
Du, J., Creson, T. K., Wu, L., Ren, M., Gray, N. A., Falke, C., Wei, Y., Wang, Y., Blumenthal, R., Machado‐Vieira, R., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3080-07.2008 · Cited by 106
Self-citationAloe, L., Properzi, G., Probert, L., Akassoglou, K., Kassiotis, G., Micera, A., & Fiore, M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01748-5 · Cited by 102
Streit (2005) · doi:10.1179/016164105x49463 · Cited by 100
Vouimba, R.-M., Muñoz, C., & Diamond, D. M. (2006) · Stress · doi:10.1080/10253890600610973 · Cited by 96 · cited 1×
“Recent studies also suggest that chronic administration of a selective serotonin reuptake inhibitor (SSRI) or an atypical antidepressant (tianeptine) increases LTP and blocks the stress-induced impairment of LTP and enhancement of LTD in the CA1 region (Holderbach et al. 2007; Vouimba et al. 2006).”
BackgroundBezchlibnyk, Y. B., Wang, J., McQueen, G. M., & Young, L. T. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00628.x · Cited by 94
Churchill, L., Rector, D. M., Yasuda, K., Fix, C. F., Rojas, M. J., Yasuda, T., & Krueger, J. M. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.066 · Cited by 94
The interferon signaling network and transcription factor C/EBP-beta.
Li, H., Gade, P., Xiao, W., & Kalvakolanu, D. V. (2007) · PubMed · Cited by 93
Pizzi, M., Sarnico, I., Boroni, F., Benarese, M., Dréano, M., Garotta, G., Valerio, A., & Spano, P. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.10.022 · Cited by 92
Ignatowski, T. A., Noble, B. K., Wright, J. R., Gorfien, J. L., Heffner, R. R., & Spengler, R. N. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00107-0 · Cited by 90
Interleukin-1β production in dysthymia before and after pharmacotherapy
Anisman, H., Ravindran, A. V., Griffiths, J., & Merali, Z. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00211-5 · Cited by 85
Depression in medical illness: The role of the immune system
Yirmiya, R. (2000) · Western Journal of Medicine · doi:10.1136/ewjm.173.5.333 · Cited by 83
Tumor necrosis factor-α gene expression in the tissues of normal mice
Hunt, J. S., Chen, H.-L., Hu, X.-L., Chen, T.-Y., & Morrison, D. C. (1992) · Cytokine · doi:10.1016/1043-4666(92)90076-4 · Cited by 80
Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression
Carpenter, L. L., Heninger, G. R., Malison, R. T., Tyrka, A. R., & Price, L. H. (2004) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00460-3 · Cited by 79
Pugh, C., Johnson, J. D., Martin, D., Rudy, J. W., Maier, S. F., & Watkins, L. R. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02445-2 · Cited by 76
Gayle, D. A., Ilyin, S. E., Flynn, M. C., & Plata‐Saláman, C. R. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00280-7 · Cited by 76
Vikman, K. S., Owe‐Larsson, B., Brask, J., Kristensson, K., & Hill, R. H. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03238-8 · Cited by 75
Rosa, A., Peralta, V., Papiol, S., Cuesta, M. J., Serrano, F., Martínez‐Larrea, A., & Fañanás, L. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20074 · Cited by 72
Mendoza-Fernández, V., Andrew, R. D., & Barajas‐López, C. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02877-8 · Cited by 72
Regulation of interleukin 6 gene expression in rat
Schöbitz, B., van den Dobbelsteen, M. E. A., Holsboer, F., Sutanto, W., & de Kloet, E. R. (1993) · Endocrinology · doi:10.1210/endo.132.4.8462455 · Cited by 71
Tumor necrosis factor and interferon: cytokines in harmony
Bartee, E., Mohamed, M. R., & McFadden, G. (2008) · Current Opinion in Microbiology · doi:10.1016/j.mib.2008.05.015 · Cited by 69
Indicators of immune activation in depressed patients
Sluzewska, A. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_4 · Cited by 66
Interleukin 1 beta enhances conditioned fear memory in rats: possible involvement of glucocorticoids
Song, C., Phillips, A. G., & Leonard, B. E. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02886.x · Cited by 66
Levkovitz, Y. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00244-x · Cited by 64
van Dam, A., Poole, S., Schultzberg, M., Zavala, F., & Tilders, F. J. H. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09557.x · Cited by 64
Maes, M. H. J. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90652-1 · Cited by 63
Reynolds, J. L., Ignatowski, T. A., Sud, R., & Spengler, R. N. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.067835 · Cited by 61
Reynolds, J. L., Ignatowski, T. A., Sud, R., & Spengler, R. N. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.02.023 · Cited by 59
The Relationship of GAP‐43 to the Development and Plasticity of Synaptic Connectionsa
Benowitz, L. I., & Perrone‐Bizzozero, N. I. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb25914.x · Cited by 59
Acute stress effects on local Il-1β responses to pathogens in a human in vivo model
Deinzer, R., Granrath, N., Stuhl, H., Twork, L., Idel, H., Waschul, B., & Herforth, A. (2004) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2003.11.008 · Cited by 58
Targeting Neurotrophic/Growth Factor Expression and Signaling for Antidepressant Drug Development
Tanis, K. Q., Newton, S. S., & Duman, R. S. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707780363276 · Cited by 57
Angioedema: Clinical and Etiological Aspects
Kulthanan, K., Jiamton, S., Boochangkool, K., & Jongjarearnprasert, K. (2007) · Clinical and Developmental Immunology · doi:10.1155/2007/26438 · Cited by 55
Sedgwick, J. D., & Czerkinsky, C. C. (1992) · Journal of Immunological Methods · doi:10.1016/0022-1759(92)90075-5 · Cited by 54
Turnbull, A. V., Pitossi, F. J., Lebrun, J. J., Lee, S., Meltzer, J. C., Nance, D. M., del Rey, A., Besedovsky, H. O., & RIVIER, C. L. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-09-03262.1997 · Cited by 52
Cytokines, Stress, and Depression
Dantzer, R., Yirmiya, R., & Wollman, E. E. (1999) · Advances in experimental medicine and biology · doi:10.1007/b102345 · Cited by 51
Low doses of interleukin-1β improve the leverpress avoidance performance of Sprague–Dawley rats
Brennan, F. X., Beck, K. D., & Servatius, R. J. (2003) · Neurobiology of Learning and Memory · doi:10.1016/s1074-7427(03)00060-1 · Cited by 50
Rettori, V., Belova, N., Kamat, A., Lyson, K., Gimeno, M. A. F., & McCann, S. M. (2006) · NeuroImmunoModulation · doi:10.1159/000097095 · Cited by 46
Gabellec, M., Griffais, R., Fillion, G., & Haour, F. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00021-5 · Cited by 43
Caspase 1 deficiency reduces inflammation-induced brain transcription
Mastronardi, C. A., Whelan, F., Yildiz, O. A., Hannestad, J. O., Elashoff, D. A., McCann, S. M., Licinio, J., & Wong, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701366104 · Cited by 42
Questions raised by the cytokine hypothesis of depression
de Beaurepaire, R. (2002) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00005-3 · Cited by 39
Cytokines, p38 MAP kinase and the pathophysiology of depression
Miller, A. H., & Raison, C. L. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301032 · Cited by 39
Analysis of IL-1α, IL-1β, and IL-RA Polymorphisms in Dysthymia
Fertuzinhos, S., de Oliveira, J. R. M., Nishimura, A. L., Pontual, D., Carvalho, D. R., Sougey, É. B., Otto, P. A., & Zatz, M. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:22:3:251 · Cited by 39
Research works printed but not linked: 8
- Manji, 2001, Psychopharmacology Bulletin, 35, 5
- Zakzanis, 1998, Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 11, 111
- Bielau, 2005, European Archives of Psychiatry and Neurological Sciences, 255, 401
- 10.1002/(sici)1098-2396(200002)35:23.0.co;2-p · DOI
- 10.1210/en.132.4.1569 · DOI
- 10.1002/(sici)1097-4547(19970515)48:43.0.co;2-7 · DOI
- Li, 2007, Cellular & Molecular Immunology, 4, 407
- Kubera, 2000, Polish Journal of Pharmacology, 52, 237
Cited by
Sorted by citations
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016) · Nature Medicine · doi:10.1038/nm.4050 · Cited by 1,750
CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies.
Valkanova, V., Ebmeier, K. P., & Allan, C. L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.06.004 · Cited by 972
Pathogenesis of depression: Insights from human and rodent studies
Ménard, C., Hodes, G. E., & Russo, S. J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.053 · Cited by 593
Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology
Schmidt, H. D., Shelton, R. C., & Duman, R. S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.151 · Cited by 491
Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity
Calabrese, F., Rossetti, A. C., Racagni, G., Gass, P., Riva, M. A., & Molteni, R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00430 · Cited by 482
Metadata
- Authors
- Khairova, R. A., Machado-Vieira, R., Du, J., & Manji, H. K.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Manji, Husseini K.
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-02-19
- Volume
- 12
- Issue
- 04
- Pages
- 561
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- PMC
- PMC2771334
- OpenAlex
- W2164978865
- Cited by
- 350
- References
- 212
- Citations by year
- 2026: 14 · 2025: 16 · 2024: 22 · 2023: 25 · 2022: 18 · 2021: 29 · 2020: 22 · 2019: 23 · 2018: 17 · 2017: 20 · 2016: 20 · 2015: 19 · 2014: 27 · 2013: 14 · 2012: 23
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Health and Human Services
- National Institutes of Health
- National Institute of Mental Health (Z01MH002835)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- major depressive disorder, inflammatory cytokines, synaptic plasticity, TNF-α, interleukin-1, neuroinflammation, cognitive impairment, treatment resistance, anti-inflammatory therapy, antidepressants
- MeSH terms
- Animals, Antidepressive Agents, Brain Chemistry, Depressive Disorder, Major, Major Depressive Disorder, Humans, Neuronal Plasticity, Cytokines, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review